NCT00851318 Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients Status COMPLETED Phase PHASE3
NCT00850343 Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients Status COMPLETED Phase PHASE3
NCT00848354 Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy Status COMPLETED Phase PHASE4
NCT00848120 A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00847886 Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT00847236 Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica Status COMPLETED Phase N/A
NCT00845949 Role of Chemokines and Proinflammatory Cytokines in Rheumatoid Synovial Pathological Changes Status WITHDRAWN Phase N/A
NCT00845832 A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate Status TERMINATED Phase PHASE2
NCT00844714 Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy Status COMPLETED Phase NA
NCT00843778 Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study Status COMPLETED Phase PHASE3
NCT00840957 Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT00839020 Minimally Invasive Versus Conventional Approaches in Navigated Total Knee Arthroplasty (TKA) Status TERMINATED Phase PHASE4
NCT00838565 Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT00838058 A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis. Status COMPLETED Phase PHASE1
NCT00837811 An Open Label Extension Study in Participants With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00832910 Assessment of Body Image in Patients With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT00831922 Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00831649 A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201 Status TERMINATED Phase PHASE2